Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Illumina,_Inc.
|
| gptkbp:acquisitionYear |
2021
|
| gptkbp:CEO |
gptkb:Bob_Ragusa
|
| gptkbp:focus |
early cancer detection
|
| gptkbp:founded |
2016
|
| gptkbp:founder |
gptkb:Illumina,_Inc.
|
| gptkbp:headquarters_location |
gptkb:Menlo_Park,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Grail, Inc.
|
| gptkbp:industry |
gptkb:biotechnology
healthcare |
| gptkbp:keyPerson |
gptkb:Hans_Bishop
gptkb:Jeff_Huber gptkb:Bob_Ragusa |
| gptkbp:mission |
detect cancer early, when it can be cured
|
| gptkbp:notableProduct |
gptkb:Galleri_multi-cancer_early_detection_test
|
| gptkbp:numberOfEmployees |
over 700
|
| gptkbp:parentCompany |
gptkb:Illumina,_Inc.
|
| gptkbp:product |
gptkb:Galleri
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://grail.com
|
| gptkbp:bfsParent |
gptkb:Illumina,_Inc.
|
| gptkbp:bfsLayer |
5
|